The University of Texas at Austin
United States of America
Since 2009 George's laboratory has been focused on the discovery and development of protein therapeutics and on the analysis of adaptive immune responsesEarlier work by the Georgiou lab had focused on redox homeostasis and protein biogenesis in bacteria and on the development of platform technologies for protein expression and engineering. These studies led to a number of mechanistic advances and to new technologies that are being used commercially for therapeutic protein manufacturing and protein engineering. Dr. Georgiou is co-inventor of 29 issued and 46 pending US patents. Notably, 16 different technology suites (comprising either one or multiple patents) have been licensed to major pharmaceutical and biotechnology companies.
Cellular and Biomolecular Engineering